Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $7.52 Analyst target: $19.17 Upside: 154.92%
electroCore, Inc., a commercial-stage medical device company, is dedicated to the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is headquartered in Rockaway, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.